chr18-9254838-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_015208.5(ANKRD12):āc.1571C>Gā(p.Ser524Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000165 in 1,492,088 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000079 ( 0 hom., cov: 32)
Exomes š: 0.00017 ( 0 hom. )
Consequence
ANKRD12
NM_015208.5 missense
NM_015208.5 missense
Scores
8
8
3
Clinical Significance
Conservation
PhyloP100: 7.57
Genes affected
ANKRD12 (HGNC:29135): (ankyrin repeat domain 12) This gene encodes a member of the ankyrin repeats-containing cofactor family. These proteins may inhibit the transcriptional activity of nuclear receptors through the recruitment of histone deacetylases. The encoded protein interacts with p160 coactivators and also represses transcription mediated by the coactivator alteration/deficiency in activation 3 (ADA3). Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD12 | NM_015208.5 | c.1571C>G | p.Ser524Cys | missense_variant | 9/13 | ENST00000262126.9 | NP_056023.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD12 | ENST00000262126.9 | c.1571C>G | p.Ser524Cys | missense_variant | 9/13 | 1 | NM_015208.5 | ENSP00000262126.3 | ||
ANKRD12 | ENST00000400020.7 | c.1502C>G | p.Ser501Cys | missense_variant | 8/12 | 1 | ENSP00000382897.3 | |||
ANKRD12 | ENST00000359158.7 | n.*685C>G | non_coding_transcript_exon_variant | 4/4 | 2 | ENSP00000352073.7 | ||||
ANKRD12 | ENST00000359158.7 | n.*685C>G | 3_prime_UTR_variant | 4/4 | 2 | ENSP00000352073.7 |
Frequencies
GnomAD3 genomes AF: 0.0000790 AC: 12AN: 151964Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
12
AN:
151964
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000599 AC: 10AN: 167030Hom.: 0 AF XY: 0.0000448 AC XY: 4AN XY: 89188
GnomAD3 exomes
AF:
AC:
10
AN:
167030
Hom.:
AF XY:
AC XY:
4
AN XY:
89188
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000175 AC: 234AN: 1340124Hom.: 0 Cov.: 33 AF XY: 0.000173 AC XY: 114AN XY: 657106
GnomAD4 exome
AF:
AC:
234
AN:
1340124
Hom.:
Cov.:
33
AF XY:
AC XY:
114
AN XY:
657106
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000790 AC: 12AN: 151964Hom.: 0 Cov.: 32 AF XY: 0.0000943 AC XY: 7AN XY: 74212
GnomAD4 genome
AF:
AC:
12
AN:
151964
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
74212
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
9
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2022 | The c.1571C>G (p.S524C) alteration is located in exon 9 (coding exon 8) of the ANKRD12 gene. This alteration results from a C to G substitution at nucleotide position 1571, causing the serine (S) at amino acid position 524 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
M;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.
REVEL
Pathogenic
Sift
Pathogenic
D;.
Sift4G
Uncertain
D;D
Polyphen
D;D
Vest4
MVP
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at